FIH Trial Trends: How far we’ve come and where we’re going with PK data

Read more

Discover an informative webinar delving into pharmacokinetics (PK) in first-in-human (FIH) studies and how it optimizes the data points in clinical trials. In the ever-evolving landscape of pharmaceutical research, it’s crucial to keep a close eye on the changes in PK in FIH trials over the past decade. These changes hold valuable insights that can significantly impact the success of clinical studies.


Chief Scientific Officer, Early Phase Development

Want to learn more about Worldwide Clinical Trials?